Sartorius AG (SOAGY)
57.43
+0.21
(+0.37%)
USD |
OTCM |
Aug 25, 16:00
Sartorius Shareholders Equity (Quarterly) : 3.227B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.227B |
| March 31, 2026 | 3.142B |
| December 31, 2025 | 3.179B |
| September 30, 2025 | 3.135B |
| June 30, 2025 | 3.120B |
| March 31, 2025 | 2.927B |
| December 31, 2024 | 2.863B |
| September 30, 2024 | 2.978B |
| June 30, 2024 | 2.901B |
| March 31, 2024 | 2.885B |
| December 31, 2023 | 2.284B |
| September 30, 2023 | 2.189B |
| June 30, 2023 | 2.222B |
| March 31, 2023 | 2.094B |
| December 31, 2022 | 2.124B |
| September 30, 2022 | 1.839B |
| June 30, 2022 | 1.742B |
| March 31, 2022 | 1.589B |
| December 31, 2021 | 1.433B |
| September 30, 2021 | 1.430B |
| June 30, 2021 | 1.447B |
| March 31, 2021 | 1.324B |
| December 31, 2020 | 1.262B |
| September 30, 2020 | 1.035B |
| June 30, 2020 | 954.68M |
| Date | Value |
|---|---|
| March 31, 2020 | 940.01M |
| December 31, 2019 | 909.68M |
| September 30, 2019 | 902.36M |
| June 30, 2019 | 878.58M |
| March 31, 2019 | 834.17M |
| December 31, 2018 | 846.58M |
| September 30, 2018 | 789.70M |
| June 30, 2018 | 752.37M |
| March 31, 2018 | 780.59M |
| December 31, 2017 | 741.85M |
| September 30, 2017 | 705.18M |
| June 30, 2017 | 660.15M |
| March 31, 2017 | 653.92M |
| December 31, 2016 | 611.41M |
| September 30, 2016 | 611.91M |
| June 30, 2016 | 576.58M |
| March 31, 2016 | 606.81M |
| December 31, 2015 | 562.41M |
| September 30, 2015 | 560.69M |
| June 30, 2015 | 529.13M |
| March 31, 2015 | 499.41M |
| December 31, 2014 | 481.55M |
| September 30, 2014 | 493.05M |
| June 30, 2014 | 502.20M |
| March 31, 2014 | 519.74M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Mesa Laboratories, Inc. | 188.76M |
| Austar Lifesciences Ltd. | -- |
| SCHOTT Pharma AG & Co. KGaA | 1.139B |
| Agilent Technologies, Inc. | 7.122B |
| Bio-Rad Laboratories, Inc. | 7.174B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.98B |
| Total Liabilities (Quarterly) | 6.407B |
| Debt to Equity Ratio | 1.436 |
| Current Ratio | 1.138 |
| Net Debt Paydown Yield | 0.81% |